Literature DB >> 12453648

Prognostic factors in patients who survived more than 10 years after undergoing surgery for metastatic brain tumors: report of 5 cases and review of the literature.

Hideo Takeshima1, Jun-ichi Kuratsu, Toru Nishi, Yukitaka Ushio.   

Abstract

BACKGROUND: Although the overall prognosis of patients with metastatic brain tumors is dismal, a small number survive longer than 10 years after craniotomy. We report 5 patients who survived for more than 10 years after undergoing treatment for metastatic brain tumor.
METHODS: The 5 patients who survived for more than 10 years after undergoing craniotomy were among 56 consecutively treated patients with solitary metastatic brain tumors. We retrospectively examined their clinical course, treatment, and variables associated with their longer survival and compared these 5 patients with other reported cases of metastatic brain tumor.
RESULTS: The histologic tumor types and the sites of origin of the primary tumor varied: two were from lung cancer and one each was from colon cancer, renal cell, and cervical carcinoma of the uterus. Common features among the long-term survivors were: systemic disease was absent, the metastatic tumor was located in the non-eloquent area of the non-dominant hemisphere, they were in good neurologic condition before surgery, there was a long interval between the diagnosis and treatment of the primary lesion and the diagnosis of the brain metastasis, and the patients received postoperative irradiation/chemotherapy.
CONCLUSION: Aggressive surgical treatment may be justified in young patients with a solitary metastatic brain tumor, as long as they are free of active systemic metastases.

Entities:  

Mesh:

Year:  2002        PMID: 12453648     DOI: 10.1016/s0090-3019(02)00753-x

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  8 in total

1.  AMD3100 inhibits brain-specific metastasis in lung cancer via suppressing the SDF-1/CXCR4 axis and protecting blood-brain barrier.

Authors:  Hongru Li; Yusheng Chen; Nengluan Xu; Meie Yu; Xunwei Tu; Zhengwei Chen; Ming Lin; Baosong Xie; Jianjun Fu; Lili Han
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Cranial metastases: first sign of colorectal cancer. Is the resection of the primary non-complicated tumour indicated when the metastases have been resected?

Authors:  Jaime Ruiz-Tovar; Aurea Tartas; José Luis Ramos; Javier Miramón; Manuel Limones
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

Review 3.  Brain metastases: epidemiology and pathophysiology.

Authors:  Igor T Gavrilovic; Jerome B Posner
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

4.  Pericytes Suppress Brain Metastasis from Lung Cancer In Vitro.

Authors:  Takashi Fujimoto; Shinsuke Nakagawa; Yoichi Morofuji; Daisuke Watanabe; Kenta Ujifuku; Nobutaka Horie; Tsuyoshi Izumo; Masami Niwa; William A Banks; Maria A Deli; Takayuki Matsuo
Journal:  Cell Mol Neurobiol       Date:  2019-08-14       Impact factor: 5.046

5.  A cure is possible: a study of 10-year survivors of brain metastases.

Authors:  Rupesh Kotecha; Sally Vogel; John H Suh; Gene H Barnett; Erin S Murphy; Chandana A Reddy; Michael Parsons; Michael A Vogelbaum; Lilyana Angelov; Alireza M Mohammadi; Glen H J Stevens; David M Peereboom; Manmeet S Ahluwalia; Samuel T Chao
Journal:  J Neurooncol       Date:  2016-07-25       Impact factor: 4.130

6.  Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasis.

Authors:  Takashi Kanou; Jiro Okami; Toshiteru Tokunaga; Ayako Fujiwara; Daisuke Ishida; Hidenori Kuno; Masahiko Higashiyama
Journal:  Surg Today       Date:  2014-04-20       Impact factor: 2.549

7.  Factors associated with long-term survival in central nervous system metastases.

Authors:  Bernardo Cacho-Díaz; Héctor Spínola-Maroño; Alberto González-Aguilar; Oscar Arrieta
Journal:  J Neurooncol       Date:  2018-07-12       Impact factor: 4.130

8.  Brain metastasis in pancreatic cancer.

Authors:  Johannes Lemke; Jan Scheele; Thomas Kapapa; Christian Rainer Wirtz; Doris Henne-Bruns; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2013-02-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.